Janux Therapeutics Inc (JANX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1999 | 12-1998 | 12-1997 | 12-1996 | 12-1995 | |
| Assets | |||||
| Current Assets | |||||
| Other current assets | 80 | 80 | 80 | 360 | 260 |
| TOTAL | $80 | $80 | $80 | $360 | $260 |
| Non-Current Assets | |||||
| Other Non-Current Assets | 270 | 400 | 443 | 2,270 | 2,430 |
| TOTAL | $270 | $400 | $443 | $2,270 | $2,430 |
| Total Assets | $350 | $480 | $523 | $2,630 | $2,690 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,030 | 600 | 680 | 800 | 350 |
| Accrued Expenses | 540 | 1,200 | 1,370 | 840 | 500 |
| Other current liabilities | 1,630 | 620 | N/A | N/A | N/A |
| TOTAL | $3,450 | $2,670 | $2,510 | $3,022 | $2,567 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $3,450 | $2,670 | $2,510 | $3,022 | $2,567 |
| Shareholders' Equity | |||||
| Common Shares | 12,800 | 12,800 | 11,610 | 11,260 | 11,050 |
| TOTAL | $13,350 | $13,350 | $12,160 | $11,810 | $11,050 |
| Total Liabilities And Equity | $16,800 | $16,020 | $14,670 | $14,832 | $13,617 |